Kathryn Van Hook

N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence

R. Sears, C. Lopez, P. Stork, 2012, Proceedings of the National Academy of Sciences.

Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor

Laura M. Heiser, Nicholas J. Wang, M. Gleave, 2016, Oncotarget.

ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.

P. Spellman, M. Dai, R. Sears, 2017, Biochemical and biophysical research communications.

Orteronel for the treatment of prostate cancer.

J. Alumkal, Kathryn Van Hook, Ted Huang, 2014, Future oncology.

Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer

Mark A. Dane, Laura M. Heiser, Nicholas J. Wang, 2017, OncoTarget.